Paragon Pharmaceutical Capital is a $650 million startup fund that launches its own life science companies and invests in innovative life science ventures.

Building Companies that Matter

Paragon partners with Suregene to improve 
mental health outcomes for patients.


Funding Breakthroughs in Medicine

Paragon works with Dublin Pharmaceuticals
to put clinical research into action.


Partners in Innovation

We help entrepreneurs launch ideas
that can improve patients’ lives.